Related Experiment Video
Updated: Apr 10, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Benefit of Blood Pressure Control in Diabetic Patients
1Center for Cardiovascular Research, CCR, Institute of Pharmacology, Charité - Universitaetsmedizin Berlin, Hessische Str.3-4, 10115, Berlin, Germany, ulrich.kintscher@charite.de.
Insights
Controlling blood pressure and blood glucose is crucial for patients with both hypertension and diabetes to reduce cardiovascular and renal risks. Recent studies, including ADVANCE-ON, highlight the sustained benefits of blood pressure lowering in this population.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Arterial hypertension and diabetes mellitus significantly increase cardiovascular risk.
- Effective management of blood pressure and blood glucose is essential for mitigating diabetes-related complications.
Purpose of the Study:
- To discuss new therapeutic targets for blood pressure management in diabetic patients.
- To evaluate the benefits of blood pressure lowering on macrovascular and microvascular endpoints.
- To analyze recent findings on long-term blood pressure control in hypertensive diabetics.
Main Methods:
- Review of clinical trial evidence on blood pressure lowering in diabetes.
- Evaluation of data from the ADVANCE-ON study.
- Discussion of current literature and emerging topics.
Main Results:
- Blood pressure lowering significantly reduces cardiovascular and renal endpoints in diabetic patients.
- Evidence for microvascular benefits (e.g., retinopathy, albuminuria) is less robust but warrants consideration.
- The ADVANCE-ON study suggests long-term, sustained benefits of blood pressure management.
Conclusions:
- Optimizing blood pressure control is a cornerstone of managing patients with coexisting hypertension and diabetes.
- Further research is needed to clarify the impact on microvascular complications.
- Sustained blood pressure lowering offers significant protection against major adverse events.
Abstract:
The coexistence of arterial hypertension and diabetes represents a devastating partnership for cardiovascular health. Thus, blood pressure and blood glucose control are essential therapeutic goals to reduce cardiovascular risk and other diabetes-related endpoints in these patients. The major benefit of blood pressure lowering in diabetes comes from a marked reduction of cardiovascular and renal endpoints. New target blood pressure values to achieve maximum cardiovascular and renal protection will be discussed. In addition to the reduction of macrovascular endpoints, blood pressure lowering therapy in diabetic patients has also been discussed to improve microvascular diseases during diabetes, in particular microalbuminuria or diabetic retinopathy. However, current clinical trial evidence is less robust than for macrovascular disease. Clinical studies showed controversial results, and will be discussed. Finally, new data from the ADVANCE-ON study about the long-term, sustained benefit of blood pressure lowering in hypertensive, diabetic patients has been recently published, and will be evaluated in the context of previous evidence. In summary, the present article will discuss selected new topics in the field of hypertension and diabetes focusing on the benefits achieved by blood pressure lowering in these patients.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Errors occurring during blood pressure monitoring
Several factors...
Antihypertensive Drugs: Action of Diuretics

